10-Q: Calumet Q1 2026 Financial Results and DOE Waiver

Calumet, Inc. reported a net loss of $317.0 million for Q1 2026, impacted by non-cash charges and production issues, while securing a limited waiver from the DOE.

Summary

• Net loss for Q1 2026 was $317.0 million, compared to a net loss of $162.0 million in Q1 2025.
• Adjusted EBITDA with Tax Attributes was $50.1 million for Q1 2026, down from $55.0 million in Q1 2025.
• Operating loss was $171.3 million, driven by significant non-cash items including a $102.7 million unrealized loss on derivatives and $147.4 million in RINs-related expenses.
• Shreveport facility experienced a temporary production loss of approximately 750,000 barrels due to feedstock contamination.
• Montana Renewables completed the MaxSAF 150 expansion and turnaround in 48 days, resuming production in Q2 2026.
• Total liquidity as of March 31, 2026, was $462.8 million.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a challenging quarter due to significant net losses and operational disruptions, though the completion of the MaxSAF 150 project provides a positive long-term catalyst.

Positives

• Successful completion of the MaxSAF 150 expansion and turnaround at the Montana Renewables facility.
• Extension of the Shreveport Supply and Offtake Agreement with J. Aron & Company LLC to January 31, 2030.
• Improved market pricing for renewable fuels and credit values following the EPA's final 2026-2027 RVO rule.
• Successful monetization of Section 45Z Clean Fuel Production Tax Credits (CFPCs).

Negatives

• Net loss widened to $317.0 million from $162.0 million in the prior year period.
• Temporary suspension of operations at the Shreveport facility due to organic chloride contamination in feedstock.
• Significant non-cash charges, including $102.7 million in unrealized derivative losses and $147.4 million in RINs expenses.
• General and administrative expenses increased to $66.0 million, largely due to $37.9 million in non-cash equity-based compensation.

Risks

• Potential for continued volatility in feedstock costs and global energy markets.
• Ongoing exposure to RINs compliance costs and regulatory uncertainty regarding SRE petitions.
• Operational risks associated with the integration of the MaxSAF 150 expansion.
• Sensitivity of financial results to commodity price fluctuations and derivative instrument performance.

Future Outlook

Management expects improved performance driven by the MaxSAF 150 expansion, resilient specialty product margins, and favorable RVO regulatory developments, despite near-term volatility in feedstock costs.

Management Comments

• Management believes the business is well-positioned to deliver improved performance supported by a diversified customer base and multi-year capital investments.
• The EPA's final RVO rule is expected to improve biobased diesel industry margins and attract producers to meet mandated demand.

Industry Context

StockSavvy.ai notes that Calumet's focus on renewable fuels and specialty products aligns with broader industry trends toward decarbonization and sustainable aviation fuel (SAF) production, though the company remains highly sensitive to RFS compliance costs and commodity price volatility.

Comparison to Industry Standards

• Calumet's transition to a renewable-focused business model is consistent with peers like Valero and Phillips 66, which are also investing in renewable diesel and SAF capacity.
• The company's reliance on SRE petitions and RINs compliance remains a distinct risk factor compared to larger, more integrated refiners.

Corporate Governance

Legal Proceedings

• The company is involved in ongoing litigation and regulatory matters incidental to its business, including SRE petition challenges.

Related Party Transactions

• Disclosed transactions with J. Aron & Company LLC under the Supply and Offtake Agreement.

Stakeholder Impact

• Shareholders may face continued volatility due to non-cash accounting charges and operational risks.
• Creditors are impacted by the extension of credit facilities and the issuance of new senior notes.

Next Steps

• Continue investigation into the source of organic chloride contamination at the Shreveport facility.
• Ramp up production following the completion of the MaxSAF 150 expansion.
• Monitor EPA decisions regarding 2025 SRE petitions.

Key Dates

Recommendation

The stock is a hold due to the significant operational progress with the MaxSAF 150 project being offset by substantial financial losses and ongoing regulatory and operational risks.

Keywords

Calumet, CLMT, Renewable Fuels, Specialty Products, MaxSAF, DOE Loan, RINs, Refining